Synthesis, biophysical characterization and anti-HIV activity of d(TG3AG) Quadruplexes bearing hydrophobic tails at the 5'-end

Bioorg Med Chem. 2014 Feb 1;22(3):960-6. doi: 10.1016/j.bmc.2013.12.051. Epub 2014 Jan 4.

Abstract

Novel conjugated G-quadruplex-forming d(TG3AG) oligonucleotides, linked to hydrophobic groups through phosphodiester bonds at 5'-end, have been synthesized as potential anti-HIV aptamers, via a fully automated, online phosphoramidite-based solid-phase strategy. Conjugated quadruplexes showed pronounced anti-HIV activity with some preference for HIV-1, with inhibitory activity invariably in the low micromolar range. The CD and DSC monitored thermal denaturation studies on the resulting quadruplexes, indicated the insertion of lipophilic residue at the 5'-end, conferring always improved stability to the quadruplex complex (20<ΔTm<40°C). The data suggest no direct functional relationship between the thermal stability and anti-HIV activity of the folded conjugated G-quartets. It would appear that the nature of the residue at 5' end of the d(TG3AG) quadruplexes plays an important role in the thermodynamic stabilization but a minor influence on the anti-HIV activity. Moreover, a detailed CD and DSC analyses indicate a monophasic behaviour for sequences I and V, while for ODNs (II-IV) clearly show that these quadruplex structures deviate from simple two-state melting, supporting the hypothesis that intermediate states along the dissociation pathway may exist.

Keywords: Anti-HIV activity; Aptamers; Conjugated oligonucleotides; G-quadruplex; Solid phase synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / chemical synthesis
  • Anti-HIV Agents / chemistry*
  • Anti-HIV Agents / metabolism
  • Anti-HIV Agents / pharmacology*
  • Aptamers, Nucleotide / chemistry
  • Calorimetry, Differential Scanning
  • Cells, Cultured / virology
  • Circular Dichroism
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical / methods
  • G-Quadruplexes*
  • HIV Envelope Protein gp120 / metabolism
  • HIV Envelope Protein gp41 / metabolism
  • HIV Reverse Transcriptase / antagonists & inhibitors
  • HIV-1 / drug effects
  • HIV-1 / pathogenicity
  • HIV-2 / drug effects
  • HIV-2 / pathogenicity
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Oligonucleotides / chemistry
  • Oligonucleotides / pharmacology
  • Serum Albumin / metabolism
  • Solid-Phase Synthesis Techniques
  • Structure-Activity Relationship
  • Surface Plasmon Resonance
  • Thermodynamics

Substances

  • Anti-HIV Agents
  • Aptamers, Nucleotide
  • HIV Envelope Protein gp120
  • HIV Envelope Protein gp41
  • Oligonucleotides
  • Serum Albumin
  • gp120 protein, Human immunodeficiency virus 1
  • gp41 protein, Human immunodeficiency virus 1
  • reverse transcriptase, Human immunodeficiency virus 1
  • HIV Reverse Transcriptase